ENTITY

Grace Therapeutics (GRCE US)

3
Analysis
Health CareUnited States
Grace Therapeutics, Inc. operates as a late-stage biopharma company. The Company focuses on drug delivery and technologies addressing rare and orphan diseases. Grace Therapeutics serves clients in Canada and the United States.
more
18 Nov 2024 23:00Issuer-paid

GRCE: FY:25 Second Quarter Results

Grace is a clinical-stage, biotechnology company focused on rare disease. Its lead program, GTX-104, is a novel injectable formulation of...

Share
05 Nov 2024 11:22Issuer-paid

Grace Therapeutics, Inc: Initiating Coverage – From Confusion to Infusion

Grace is a clinical-stage, biotechnology company focused on rare disease.Its lead program is for GTX-104, a novel injectable formulation of...

Share
x